clinical trial · NCT05595642
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Hoffmann-La Roche·phase3·recruiting·n = 1,290
Chronic Obstructive Pulmonary Disease (COPD)AstegolimabPlacebo
brief summary
This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COPD) who are former or current smokers and have a history of frequent exacerbations.
started
Dec 29, 2022
primary completion
Jun 24, 2025
completion
Sep 24, 2027
last updated
Apr 2, 2026
official title
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol